|
|
Therapeutic potential and challenges of targeting
sirtuins in neurodegenerative diseases |
Li GAN, |
Gladstone Institute of
Neurological Disease and Department of Neurology, University of California,
San Francisco 94158, USA; |
|
|
Abstract Aging is the predominant risk factor for major neurodegenerative diseases. The underlying mechanisms are largely unknown. Members of the sirtuin family of protein deacetylases support and promote longevity in diverse organisms and can extend lifespan when upregulated. Sirtuins are involved in fundamental mechanisms in age-related neurodegenerative diseases, including protein aggregation and homeostasis, survival and stress responses, and inflammatory processes. In this review, we will discuss the neurobiology of sirtuins and their multifaceted roles in the pathogenesis of neurodegenerative diseases. We will also examine the potential and challenges of targeting sirtuin pathways to treat these devastating conditions.
|
Keywords
Sirtuins
aging
neurodegenerative disease
|
Issue Date: 01 August 2010
|
|
|
Adler A S, Kawahara T L, Segal E, Chang H Y (2008). Reversal of aging by NFkappaB blockade. Cell Cycle, 7(5): 556–559
|
|
Adler A S, Sinha S, Kawahara T L, Zhang J Y, Segal E, Chang H Y (2007). Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev, 21(24): 3244–3257
doi: 10.1101/gad.1588507
|
|
|
|
Berdichevsky A, Viswanathan M, Horvitz H R, Guarente L (2006). C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell, 125(6): 1165–1177
|
|
Bordone L, Cohen D, Robinson A, Motta M C, van Veen E, Czopik A, Steele A D, Crowe H, Marmor S, Luo J, Gu W, Guarente L (2007). SIRT1 transgenic mice show phenotypes resembling calorierestriction. Aging Cell, 6(6): 759–767
doi: 10.1111/j.1474-9726.2007.00335.x
|
|
Borra M T, Smith B C, Denu J M (2005). Mechanism of human SIRT1 activation by resveratrol. J Biol Chem, 280(17): 17187–17195
doi: 10.1074/jbc.M501250200
|
|
Brunet A, Sweeney L B, Sturgill J F, Chua K F, Greer P L, Lin Y, Tran H, Ross S E, Mostoslavsky R, Cohen H Y, Hu L S, Cheng H L, Jedrychowski M P, Gygi S P, Sinclair D A, Alt F W, Greenberg M E (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 303(5666): 2011–2015
doi: 10.1126/science.1094637
|
|
Buck S W, Gallo C M, Smith J S (2004). Diversity in the Sir2 family of protein deacetylases. J Leukoc Biol, 75(6): 939–950
doi: 10.1189/jlb.0903424
|
|
Cao S X, Dhahbi J M, Mote P L, Spindler S R (2001). Genomic profiling of short- and long-termcaloric restriction effects in the liver of aging mice. Proc Natl Acad Sci U S A, 98(19): 10630–10635
doi: 10.1073/pnas.191313598
|
|
Chen D, Steele A D, Hutter G, Bruno J, Govindarajan A, Easlon E, Lin S J, Aguzzi A, Lindquist S, Guarente L (2008). The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp Gerontol, 43(12): 1086–1093
doi: 10.1016/j.exger.2008.08.050
|
|
Chen D, Steele A D, Lindquist S, Guarente L (2005a). Increase in activity during calorie restriction requires Sirt1. Science, 310(5754): 1641
doi: 10.1126/science.1118357
|
|
Chen J, Zhou Y, Mueller-Steiner S, Chen L F, Kwon H, Yi S, Mucke L, Gan L (2005b). SIRT1 protects againstmicroglia-dependent amyloid-beta toxicity through inhibiting NF-kappaBsignaling. J Biol Chem, 280(48): 40364–40374
doi: 10.1074/jbc.M509329200
|
|
Cohen E, Bieschke J, Perciavalle R M, Kelly J W, Dillin A (2006). Opposing activities protect against age-onset proteotoxicity. Science, 313(5793): 1604–1610
doi: 10.1126/science.1124646
|
|
Cohen E, Du D, Joyce D, Kapernick E A, Volovik Y, Kelly J W, Dillin A (2010). Temporal requirements of insulin/IGF-1 signaling forproteotoxicity protection. Aging Cell, 9(2): 126–134
doi: 10.1111/j.1474-9726.2009.00541.x
|
|
Cohen H Y, Miller C, Bitterman K J, Wall N R, Hekking B, Kessler B, Howitz K T, Gorospe M, de Cabo R, Sinclair D A (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 305(5682): 390–392
doi: 10.1126/science.1099196
|
|
Cui L, Jeong H, Borovecki F, Parkhurst C N, Tanese N, Krainc D (2006). Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127(1): 59–69
|
|
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia M P, Invidia L, Celani L, Scurti M, Cevenini E, Castellani G C, Salvioli S (2007). Inflammaging and anti-inflammaging: a systemic perspectiveon aging and longevity emerged from studies in humans. Mech Ageing Dev, 128(1): 92–105
doi: 10.1016/j.mad.2006.11.016
|
|
Frye R A (2000). Phylogenetic classification of prokaryoticand eukaryotic Sir2-like proteins. Biochem Biophys Res Commun, 273(2): 793–798
doi: 10.1006/bbrc.2000.3000
|
|
Gan L, Mucke L (2008). Paths of convergence: sirtuins in aging and neurodegeneration. Neuron, 58(1): 10–14
doi: 10.1016/j.neuron.2008.03.015
|
|
Gr?nroos E, Hellman U, Heldin C H, Ericsson J (2002). Control of Smad7 stability by competitionbetween acetylation and ubiquitination. Mol Cell, 10(3): 483–493
doi: 10.1016/S1097-2765(02)00639-1
|
|
Hardy J, Selkoe D J (2002). The amyloid hypothesis of Alzheimer’s disease:progress and problems on the road to therapeutics. Science, 297(5580): 353–356
doi: 10.1126/science.1072994
|
|
Hirschey M D, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard D B, Grueter C A, Harris C, Biddinger S, Ilkayeva O R, Stevens R D, Li Y, Saha A K, Ruderman N B, Bain J R, Newgard C B, Farese R V Jr, Alt F W, Kahn C R, Verdin E (2010). SIRT3 regulates mitochondrial fatty-acid oxidation byreversible enzyme deacetylation. Nature, 464(7285): 121–125
doi: 10.1038/nature08778
|
|
Ito A, Kawaguchi Y, Lai C H, Kovacs J J, Higashimoto Y, Appella E, Yao T P (2002). MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J, 21(22): 6236–6245
doi: 10.1093/emboj/cdf616
|
|
Jin Y H, Jeon E J, Li Q L, Lee Y H, Choi J K, Kim W J, Lee K Y, Bae S C (2004). Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibitsubiquitination-mediated degradation. J Biol Chem, 279(28): 29409–29417
doi: 10.1074/jbc.M313120200
|
|
Joseph S B, Castrillo A, Laffitte B A, Mangelsdorf D J, Tontonoz P (2003). Reciprocal regulation of inflammation and lipid metabolismby liver X receptors. Nat Med, 9(2): 213–219
doi: 10.1038/nm820
|
|
Kabe Y, Ando K, Hirao S, Yoshida M, Handa H (2005). Redox regulation of NF-kappaB activation: distinct redox regulation betweenthe cytoplasm and the nucleus. Antioxid Redox Signal, 7(3―4): 395–403
doi: 10.1089/ars.2005.7.395
|
|
Kaeberlein M, Kirkland K T, Fields S, Kennedy B K (2004). Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol, 2(9): E296
doi: 10.1371/journal.pbio.0020296
|
|
Kaeberlein M, McVey M, Guarente L (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by twodifferent mechanisms. Genes Dev, 13(19): 2570–2580
doi: 10.1101/gad.13.19.2570
|
|
Kawahara T L, Michishita E, Adler A S, Damian M, Berber E, Lin M, McCord R A, Ongaigui K C, Boxer L D, Chang H Y, Chua K F (2009). SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependentgene expression and organismal life span. Cell, 136(1): 62–74
|
|
Kenyon C (2001). A conserved regulatory system foraging. Cell, 105(2): 165–168
|
|
Kim D, Nguyen M D, Dobbin M M, Fischer A, Sananbenesi F, Rodgers J T, Delalle I, Baur J A, Sui G, Armour S M, Puigserver P, Sinclair D A, Tsai L H (2007). SIRT1 deacetylase protects against neurodegeneration in models forAlzheimer’s disease and amyotrophic lateral sclerosis. EMBO J, 26(13): 3169–3179
doi: 10.1038/sj.emboj.7601758
|
|
Kim S C, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin N V, White M, Yang X J, Zhao Y (2006). Substrate and functional diversityof lysine acetylation revealed by a proteomics survey. Mol Cell, 23(4): 607–618
doi: 10.1016/j.molcel.2006.06.026
|
|
Klein W L (2002). Abeta toxicity in Alzheimer’sdisease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int, 41(5): 345–352
doi: 10.1016/S0197-0186(02)00050-5
|
|
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006). Resveratrol improves mitochondrial function and protects against metabolic diseaseby activating SIRT1 and PGC-1alpha. Cell, 127(6): 1109–1122
|
|
Lee I H, Cao L, Mostoslavsky R, Lombard D B, Liu J, Bruns N E, Tsokos M, Alt F W, Finkel T (2008). A role for the NAD-dependent deacetylaseSirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A, 105(9): 3374–3379
doi: 10.1073/pnas.0712145105
|
|
Lesné S, Koh M T, Kotilinek L, Kayed R, Glabe C G, Yang A, Gallagher M, Ashe K H (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature, 440(7082): 352–357
|
|
Levine B, Kroemer G (2008). Autophagy in the pathogenesis of disease. Cell, 132(1): 27–42
|
|
Li X, Zhang S, Blander G, Tse J G, Krieger M, Guarente L (2007). SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell, 28(1): 91–106
doi: 10.1016/j.molcel.2007.07.032
|
|
Li Y, Xu W, McBurney M W, Longo V D (2008). SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab, 8(1): 38–48
doi: 10.1016/j.cmet.2008.05.004
|
|
Lin M T, Beal M F (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerativediseases. Nature, 443(7113): 787–795
doi: 10.1038/nature05292
|
|
Lin S J, Defossez P A, Guarente L (2000). Requirement of NAD and SIR2 for life-span extension by calorie restriction inSaccharomyces cerevisiae. Science, 289(5487): 2126–2128
doi: 10.1126/science.289.5487.2126
|
|
Lu T, Pan Y, Kao S Y, Li C, Kohane I, Chan J, Yankner B A (2004). Gene regulation and DNA damage in the ageing human brain. Nature, 429(6994): 883–891
doi: 10.1038/nature02661
|
|
Luo J, Nikolaev A Y, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001). Negativecontrol of p53 by Sir2? promotes cell survival under stress. Cell, 107(2): 137–148
|
|
Mattson M P, Meffert M K (2006). Roles for NF-kappaB in nerve cell survival, plasticity,and disease. Cell Death Differ, 13(5): 852–860
doi: 10.1038/sj.cdd.4401837
|
|
|
|
Morley J F, Brignull H R, Weyers J J, Morimoto R I (2002). The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influencedby aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A, 99(16): 10417–10422
doi: 10.1073/pnas.152161099
|
|
Pacholec M, Bleasdale J E, Chrunyk B, Cunningham D, Flynn D, Garofalo R S, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, Ahn K (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem, 285(11): 8340–8351
doi: 10.1074/jbc.M109.088682
|
|
Parker J A, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Néri C (2005). Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet, 37(4): 349–350
doi: 10.1038/ng1534
|
|
Peck B, Chen C Y, Ho K K, Di Fruscia P, Myatt S S, Coombes R C, Fuchter M J, Hsiao C D, Lam E W (2010). SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol Cancer Ther, 9(4): 844–855
doi: 10.1158/1535-7163.MCT-09-0971
|
|
Pinkston-Gosse J, Kenyon C (2007). DAF-16/FOXO targets genes that regulate tumor growthin Caenorhabditis elegans. Nat Genet, 39(11): 1403–1409
doi: 10.1038/ng.2007.1
|
|
Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers J T, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve A A, Pasinetti G M (2006). Neuronal SIRT1 activation as a novel mechanism underlyingthe prevention of Alzheimer disease amyloid neuropathology by calorierestriction. J Biol Chem, 281(31): 21745–21754
doi: 10.1074/jbc.M602909200
|
|
Rass U, Ahel I, West S C (2007). Defective DNA repair and neurodegenerative disease. Cell, 130(6): 991–1004
|
|
Rodgers J T, Lerin C, Haas W, Gygi S P, Spiegelman B M, Puigserver P (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature, 434(7029): 113–118
doi: 10.1038/nature03354
|
|
Rogina B, Helfand S L (2004). Sir2 mediates longevity in the fly through a pathwayrelated to calorie restriction. Proc Natl Acad Sci U S A, 101(45): 15998–16003
doi: 10.1073/pnas.0404184101
|
|
Saunders L R, Verdin E (2007). Sirtuins: critical regulators at the crossroads betweencancer and aging. Oncogene, 26(37): 5489–5504
doi: 10.1038/sj.onc.1210616
|
|
Solomon J M, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano P S, Huber L J (2006). Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival followingDNA damage. Mol Cell Biol, 26(1): 28–38
|
|
Sun Y, Yao J, Kim T W, Tall A R (2003). Expression of liver X receptor target genes decreasescellular amyloid beta peptide secretion. J Biol Chem, 278(30): 27688–27694
doi: 10.1074/jbc.M300760200
|
|
Tanner K G, Landry J, Sternglanz R, Denu J M (2000). Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a uniqueproduct, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci U S A, 97(26): 14178–14182
doi: 10.1073/pnas.250422697
|
|
Tanzi R E, Bertram L (2005). Twenty years of the Alzheimer’s disease amyloidhypothesis: a genetic perspective. Cell, 120(4): 545–555
|
|
Tissenbaum H A, Guarente L (2001). Increased dosage of a sir-2 gene extends lifespan inCaenorhabditis elegans. Nature, 410(6825): 227–230
doi: 10.1038/35065638
|
|
Vaziri H, Dessain S K, Ng Eaton E, Imai S I, Frye R A, Pandita T K, Guarente L, Weinberg R A (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell, 107(2): 149–159
|
|
Wood J G, Rogina B, Lavu S, Howitz K, Helfand S L, Tatar M, Sinclair D (2004). Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430(7000): 686–689
doi: 10.1038/nature02789
|
|
Yeung F, Hoberg J E, Ramsey C S, Keller M D, Jones D R, Frye R A, Mayo M W (2004). Modulation of NF-kappaB-dependent transcription andcell survival by the SIRT1 deacetylase. EMBO J, 23(12): 2369–2380
doi: 10.1038/sj.emboj.7600244
|
|
Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan E G, Landreth G E, Vinters H V, Tontonoz P (2007). Attenuation of neuroinflammation and Alzheimer’sdisease pathology by liver x receptors. Proc Natl Acad SciU S A, 104(25): 10601–10606
doi: 10.1073/pnas.0701096104
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|